(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Abraxas Petroleum Corporation, Twitter, and Athersys.

Rank Financial Asset Price Change Updated (EST)
1 Abraxas Petroleum Corporation (AXAS) 1.10 32.53% 2022-10-03 21:08:09
2 Twitter (TWTR) 51.77 21.7% 2022-10-04 14:54:43
3 Athersys (ATHX) 2.19 18.38% 2022-10-03 19:12:06
4 Peloton (PTON) 8.77 17.47% 2022-10-04 14:44:38
5 Royal Caribbean Cruises (RCL) 43.91 16.81% 2022-10-04 14:55:25
6 Norwegian Cruise Line (NCLH) 13.31 16.71% 2022-10-04 14:44:51
7 Marathon (MARA) 12.78 15.34% 2022-10-04 14:57:49
8 Carnival Plc (CUK) 6.89 14.75% 2022-10-04 14:58:20
9 BGC Partners (BGCP) 3.60 14.65% 2022-10-03 23:47:14
10 AMC (AMC) 7.86 14.24% 2022-10-04 14:51:39

The three biggest losers today are China Jo-Jo Drugstores, Broadwind, and Asure Software.

Rank Financial Asset Price Change Updated (EST)
1 China Jo-Jo Drugstores (CJJD) 1.74 -6.45% 2022-10-04 15:06:08
2 Broadwind (BWEN) 2.83 -6.29% 2022-10-04 05:10:06
3 Asure Software (ASUR) 5.37 -6.12% 2022-10-03 19:08:06
4 Accelerate Diagnostics (AXDX) 1.43 -5.92% 2022-10-03 21:09:06
5 Ascent Solar Technologies (ASTI) 4.30 -5.49% 2022-10-03 19:07:05
6 Cara Therapeutics (CARA) 8.88 -5.13% 2022-10-04 07:11:06
7 Catalyst Pharmaceuticals (CPRX) 12.69 -3.46% 2022-10-04 14:56:37
8 ProShares UltraShort Nasdaq Biotechnology (BIS) 24.47 -3.17% 2022-10-04 01:09:06
9 bluebird bio (BLUE) 6.13 -3.16% 2022-10-04 01:44:14
10 BioLife Solutions (BLFS) 22.17 -2.55% 2022-10-04 01:23:14

Winners today

1. Abraxas Petroleum Corporation (AXAS) – 32.53%

Abraxas Petroleum Corporation is an independent energy company that focuses on the acquisition, exploration and exploitation of oil and natural gas properties throughout the United States. It operates oil and natural gas assets throughout the Permian/Delaware Basin, Rocky Mountain and Rocky Mountain regions. Its net proven reserves, as of December 31, 2020 were estimated at 16.8 million barrels oil equivalent. It was established in San Antonio in Texas in 1977.

NASDAQ ended the session with Abraxas Petroleum Corporation jumping 32.53% to $1.10 on Tuesday while NASDAQ jumped 3.34% to $11,176.41.

Earnings Per Share

As for profitability, Abraxas Petroleum Corporation has a trailing twelve months EPS of $4.27.

PE Ratio

Abraxas Petroleum Corporation has a trailing twelve months price to earnings ratio of 0.26. Meaning,
the purchaser of the share is investing $0.26 for every dollar of annual earnings.

Yearly Top and Bottom Value

Abraxas Petroleum Corporation’s stock is valued at $1.10 at 17:32 EST, way under its 52-week high of $4.94 and way above its 52-week low of $0.52.

Sales Growth

Abraxas Petroleum Corporation’s sales growth is 65.6% for the ongoing quarter and 79.7% for the next.

More news about Abraxas Petroleum Corporation.

2. Twitter (TWTR) – 21.7%

Twitter, Inc. is a social media platform that allows people to express themselves and have real-time conversations. Twitter is the company’s main product. It allows people to create, consume, distribute and discover content. The company also offers promoted products which allow advertisers to advertise brands, products and services. The company’s promoted products include Twitter Amplify and Follower Ads as well as promoted ads. The company also offers monetization products to creators. These include Tips, which allows creators to send one-time small payments to Twitter via various payment methods including bitcoin. Super Follows is a monthly paid subscription that includes bonus content and previews. Ticketed Spaces supports creators by paying them for hosting and managing the Twitter Spaces public discussion. It also offers data partners and products to developers, including the Twitter Developer Platform. This platform allows developers to create tools for businesses and people using its public API. Partners with commercial uses of Twitter data can get paid access to Twitter data. Twitter, Inc. was established in 2006 in San Francisco, California.

NYSE ended the session with Twitter rising 21.7% to $51.77 on Tuesday, after two sequential sessions in a row of losses. NYSE rose 3.35% to $14,319.49, following the last session’s upward trend on what was a very up trend exchanging session today.

Stock rises in Twitter after a report that Musk will purchase the company for the price of the offer
Bloomberg News reported that Musk wrote a letter to Twitter to express concerns over bot activity and to say that he thought the management team was not accurate in their public disclosures regarding the amount of spam activity.

SPAC backs Trump’s truth social hit news musk offers to purchase twitter again at the original price
Tesla’s chief executive raised concerns over the existence of bots on Twitter. He also stated that he believes the management team was not accurate when it made public disclosures regarding the amount of spam activity. After news that Elon Musk has offered to buy Twitter Inc. for $54.20 per share, shares of Digital World Acquisition Corp. (or SPAC), fell 4.4% on Tuesday.

Tesla shares rebound after CEO Elon Musk offers to purchase twitter at the original price
Tesla Inc. shares edged up 0.7% Tuesday afternoon, to recover from a previous gain of 6.2%. This was after Elon Musk’s report that Tesla Inc.’s chief executive is open to buying Twitter Inc., which had lost 12.4%.

This is what Twitter users have to say about musk.
Elon Musk wrote a note to Twitter to inform them that he would continue with his original proposal and was excited about Musk’s decision to move ahead with the deal. Also, see: SPAC backs Trump’s Truth Social Hit by news Musk offers to buy Twitter again at the original price

Earnings Per Share

As for profitability, Twitter has a trailing twelve months EPS of $-1.34.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.64%.

Sales Growth

Twitter’s sales growth for the next quarter is 0.6%.

More news about Twitter.

3. Athersys (ATHX) – 18.38%

Athersys, Inc. is a biotech company that focuses on research and development in the area of regenerative medicine. The company’s clinical programs focus on neurological and cardiovascular conditions as well as inflammatory and immuno disorders. MultiStem cell treatment, an allogeneic stem-cell product that the company is leading, is currently in Phase III clinical trial for patients who have suffered from neurologic damage due to an ischemic stroke. It also has Phase II clinical studies for patients with acute coronary infarction. Phase I clinical research was completed for patients suffering leukemia and other blood-borne diseases. MultiStem cell technology is also being developed by the company to encourage tissue repair and healing in animal patients. Healios K.K. has granted the company licenses and collaborated with it. MultiStem Cell Therapy for Ischemic Stroke, Acute Respiratory Distress Syndrome, Ophthalmological Indications and Treatment of Liver, Kid, Pancreas and Inner Tissue Diseases. The University of Minnesota has also been granted license and collaboration agreements. Athersys, Inc., was established in Cleveland, Ohio in 1995.

NASDAQ ended the session with Athersys rising 18.38% to $2.19 on Tuesday, after two successive sessions in a row of gains. NASDAQ rose 3.34% to $11,176.41, following the last session’s upward trend on what was a very bullish trend exchanging session today.

Earnings Per Share

As for profitability, Athersys has a trailing twelve months EPS of $-0.357.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -867.54%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Athersys’s EBITDA is -75.12.

Yearly Top and Bottom Value

Athersys’s stock is valued at $2.19 at 17:33 EST, way under its 52-week high of $35.50 and way above its 52-week low of $1.13.

Volatility

Athersys’s last week, last month’s, and last quarter’s current intraday variation average was a positive 15.56%, a negative 0.60%, and a positive 10.78%, respectively.

Athersys’s highest amplitude of average volatility was 15.56% (last week), 13.13% (last month), and 10.78% (last quarter), respectively.

More news about Athersys.

4. Peloton (PTON) – 17.47%

Peloton Interactive, Inc. offers interactive products for fitness in North America as well as internationally. Peloton Interactive, Inc. offers connected products that stream live or on-demand classes using a touchscreen. It is available under the Peloton Bike+ and Peloton Bike+ brands. Peloton Digital App for connected subscribers allows them to access its classes. It had 5.9 million subscribers as of June 30, 2021. It sells interactive fitness products through retail stores and on onepeloton.com. Peloton Interactive, Inc., was established in 2012. It is located in New York, New York.

NASDAQ ended the session with Peloton rising 17.47% to $8.77 on Tuesday while NASDAQ jumped 3.34% to $11,176.41.

Earnings Per Share

As for profitability, Peloton has a trailing twelve months EPS of $-2.14.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -100.66%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 23.6%, now sitting on 3.84B for the twelve trailing months.

Previous days news about Peloton

  • Peloton stock gains after company reaches deal to put bikes in hilton hotels. According to MarketWatch on Monday, 3 October, "Peloton Interactive Inc. said Monday that it had reached an agreement with Hilton Hotels Corp. to put Peloton bikes in the hotel chain’s entire U.S. portfolio of locations. ", "Through the arrangement, Peloton expects that nearly all of its 5,400 Hilton-branded hotels in the U.S. will have at least one Peloton bike. "

More news about Peloton.

5. Royal Caribbean Cruises (RCL) – 16.81%

Royal Caribbean Cruises Ltd. is a worldwide cruise operator. It operates around 1,000 different itineraries under its brands Royal Caribbean International and Celebrity Cruises. It operated 61 vessels as of February 25, 2022. It was established in 1968, and its headquarters are in Miami.

NYSE ended the session with Royal Caribbean Cruises jumping 16.81% to $43.91 on Tuesday while NYSE jumped 3.35% to $14,319.49.

Earnings Per Share

As for profitability, Royal Caribbean Cruises has a trailing twelve months EPS of $-24.62.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -79.25%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 118.5% and 96.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4190.1%, now sitting on 4.68B for the twelve trailing months.

Volatility

Royal Caribbean Cruises’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.73%, a negative 0.58%, and a positive 3.98%, respectively.

Royal Caribbean Cruises’s highest amplitude of average volatility was 9.10% (last week), 3.97% (last month), and 3.98% (last quarter), respectively.

More news about Royal Caribbean Cruises.

6. Norwegian Cruise Line (NCLH) – 16.71%

Norwegian Cruise Line Holdings Ltd. and its subsidiaries operate as a cruise line in North America, Europe. Asia-Pacific, Asia-Pacific, Europe, Asia-Pacific, internationally. It operates three brands: Oceania Cruises and Regent Seven Seas Cruises. The company offers itineraries that range from 3 days to 180 days and visit various destinations, such as the Mediterranean, Greece, Scandinavia, Russia and New England. The company owned 28 vessels with approximately 59.150 berths as of December 31, 2021. The company distributes products via retail/travel advisor, onboard sales channels and meetings, incentives and charters. Norwegian Cruise Line Holdings Ltd. is an American company that was established in 1966. Its headquarters are in Miami, Florida.

NASDAQ ended the session with Norwegian Cruise Line rising 16.71% to $13.31 on Tuesday while NASDAQ rose 3.34% to $11,176.41.

Earnings Per Share

As for profitability, Norwegian Cruise Line has a trailing twelve months EPS of $-15.75.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -139.99%.

Volume

Today’s last reported volume for Norwegian Cruise Line is 36978800 which is 80.93% above its average volume of 20437500.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16736.8%, now sitting on 1.17B for the twelve trailing months.

More news about Norwegian Cruise Line.

7. Marathon (MARA) – 15.34%

Marathon Digital Holdings, Inc. is a company that produces digital assets. It mines cryptocurrency with an emphasis on the Blockchain ecosystem and the creation of digital assets in the United States. It had 8,115 bitcoins as of December 31, 2021. This includes the 4,794 bitcoins in its investment fund. Marathon Patent Group, Inc. was the company’s former name. In February 2021, Marathon Digital Holdings, Inc. took over its business. Marathon Digital Holdings, Inc. is an American company that was founded in 2010. Its headquarters are located in Las Vegas, Nevada.

NASDAQ ended the session with Marathon rising 15.34% to $12.78 on Tuesday, following the last session’s upward trend. NASDAQ jumped 3.34% to $11,176.41, following the last session’s upward trend on what was a very bullish trend trading session today.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-0.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.18%.

Previous days news about Marathon

  • Energy stocks surge as oil prices jump, led by marathon petroleum's biggest gain in over a year. According to MarketWatch on Monday, 3 October, "The ETF’s biggest gainer was Marathon Oil Corp.’s stock , which climbed 9.2%, toward the biggest one-day gain since it soared 13.6% on June 21, 2021. "

More news about Marathon.

8. Carnival Plc (CUK) – 14.75%

Carnival Corporation & plc operates as a leisure travel company. The ships are operated under Carnival Cruise Line and Princess Cruises brands. It also offers port destinations, other services and has its own hotels, lodges as well as glass-domed railway cars, motor coaches, and private jets. The company sells cruises through agents, travel planners, holiday planners and websites. It operates internationally, including in the United States and Canada. There are 87 vessels with 223 000 lower berths. Carnival Corporation & plc is a Florida-based company that was established in 1972.

NYSE ended the session with Carnival Plc rising 14.75% to $6.89 on Tuesday, after five sequential sessions in a row of losses. NYSE rose 3.35% to $14,319.49, following the last session’s upward trend on what was a very positive trend exchanging session today.

Earnings Per Share

As for profitability, Carnival Plc has a trailing twelve months EPS of $-13.02.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -70.26%.

More news about Carnival Plc.

9. BGC Partners (BGCP) – 14.65%

BGC Partners, Inc. is a financial technology and brokerage company that operates in the United States, Canada, Europe, Britain, Latin America, Asia, Africa, Middle East, and globally. Fixed income products include government bonds, corporate bonds and other debt instruments. It also offers fixed income and equity derivatives, cash equities and cash equities. Other services include trading execution, brokerage and clearing, trade compression and post-trade information. It also offers financial technology solutions and market data. The company also offers screen-based market services, which allow its customers to create a marketplace and trade with their clients, issue debt and trade odd lot, as well access the network and intellectual property. It can also provide option pricing, analysis tools, software, and infrastructure for technology and transactional elements. The company serves investors, corporations, banks, brokers-dealers and investment banks. BGC Partners, Inc., was established in 1972. It is located in New York, New York.

NASDAQ ended the session with BGC Partners rising 14.65% to $3.60 on Tuesday while NASDAQ rose 3.34% to $11,176.41.

Earnings Per Share

As for profitability, BGC Partners has a trailing twelve months EPS of $0.206.

PE Ratio

BGC Partners has a trailing twelve months price to earnings ratio of 17.48. Meaning,
the purchaser of the share is investing $17.48 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.28%.

More news about BGC Partners.

10. AMC (AMC) – 14.24%

Through its subsidiaries, AMC Entertainment Holdings, Inc. engages in theatrical exhibitions. It owns or operates theatres in Europe and the United States. It operated approximately 950 theaters and 10600 screens as of March 1, 2022. It was established in 1920. The headquarters are in Leawood in Kansas.

NYSE ended the session with AMC jumping 14.24% to $7.86 on Tuesday while NYSE jumped 3.35% to $14,319.49.

AMC Investment Hycroft Mining discloses violation of nasdaq Listing Requirement
After AMC Entertainment Holdings Inc. plunged 20%, Hycroft was made well-known to investors.

AMC stock news: AMC Entertainment, APE shares fall to begin October
AMC shares fell 1.3% Monday and ended the trading session with a closing price of $6.88. AMC preferred units and APE both fell to new 52 week lows, while AMC Entertainment’s combined equity tickers reached a $9.32 price.

Earnings Per Share

As for profitability, AMC has a trailing twelve months EPS of $-39.15.

Volume

Today’s last reported volume for AMC is 40456900 which is 4% below its average volume of 42143600.

Yearly Top and Bottom Value

AMC’s stock is valued at $7.86 at 17:33 EST, way below its 52-week high of $45.95 and way above its 52-week low of $6.81.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AMC’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth grew by 429.8%, now sitting on 3.17B for the twelve trailing months.

Previous days news about AMC

  • AMC stock news: AMC entertainment falls as APE dilution continues to spook investors. According to FXStreet on Monday, 3 October, "Meme stocks also fell alongside AMC as the aforementioned APE shares hit a new all-time low price after losing 6.6% on Friday. ", "After a filing last week showed that the company could exerciseup to 425 million additional units of APE into AMC common stock, investors are likely worried about further dilution. "

More news about AMC.

Losers Today

1. China Jo-Jo Drugstores (CJJD) – -6.45%

China Jo-Jo Drugstores, Inc., along with its subsidiaries, is a distributor and retailer of healthcare products and pharmaceuticals in the People’s Republic of China. It operates in four areas: Online Pharmacy, Retail Drugstores and Drug Wholesale. The company’s pharmacies sell a variety of pharmaceutical products including over-the-counter and prescription drugs as well as nutritional supplements and traditional Chinese medicines (TCM), as well as personal and family care products and medical devices. It also offers convenience products such as seasonal and consumable products. It also has licensed Western Medicine and TCM doctors on-site for consultations, examinations, and common ailments treatment at set hours. It also has an online pharmacy that sells OTC medications and nutritional supplements. The company also distributes third party pharmaceutical products to traders, and grows and wholesales TCM herbs. It had 4 drugstores and 109 retail pharmacies as of the Jiuzhou Grand Pharmacy date. Hangzhou is the headquarters of this company, which was established in 2003.

NASDAQ ended the session with China Jo-Jo Drugstores dropping 6.45% to $1.74 on Tuesday, following the last session’s downward trend. NASDAQ rose 3.34% to $11,176.41, following the last session’s upward trend on what was a very bullish trend exchanging session today.

Earnings Per Share

As for profitability, China Jo-Jo Drugstores has a trailing twelve months EPS of $-1.864.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.57%.

Volume

Today’s last reported volume for China Jo-Jo Drugstores is 104960 which is 49.65% above its average volume of 70134.

Revenue Growth

Year-on-year quarterly revenue growth grew by 20.3%, now sitting on 164.39M for the twelve trailing months.

Moving Average

China Jo-Jo Drugstores’s worth is way under its 50-day moving average of $2.50 and way under its 200-day moving average of $3.06.

Yearly Top and Bottom Value

China Jo-Jo Drugstores’s stock is valued at $1.74 at 17:33 EST, way below its 52-week high of $11.76 and above its 52-week low of $1.67.

More news about China Jo-Jo Drugstores.

2. Broadwind (BWEN) – -6.29%

Broadwind, Inc. is a manufacturer and seller of components, equipment, structures, and parts for clean technology and other specialized uses, primarily in the United States. The company operates in three main segments, Heavy Fabrications and Gearing. Heavy Fabrications provides manufacturing services to many industrial markets. Steel towers are also available for adapters and wind turbine makers. Gearing offers gearing and system gearboxes for offshore and onshore oil and gas drilling, surface or underground mining, wind energy and steel as well as material handling and other infrastructure markets. Industrial Solutions provides services for the natural gas turbine market, including supply chain management and inventory management. Through its independent sales representatives and direct sales, the company sells products to customers in energy, mining and infrastructure sectors. Broadwind Energy, Inc. was the company’s former name. In May 2020, Broadwind, Inc. became Broadwind, Inc. Broadwind, Inc. has its headquarters in Cicero, Illinois.

NASDAQ ended the session with Broadwind dropping 6.29% to $2.83 on Tuesday, following the last session’s downward trend. NASDAQ rose 3.34% to $11,176.41, following the last session’s upward trend on what was a very positive trend exchanging session today.

Earnings Per Share

As for profitability, Broadwind has a trailing twelve months EPS of $0.13.

PE Ratio

Broadwind has a trailing twelve months price to earnings ratio of 21.77. Meaning,
the purchaser of the share is investing $21.77 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.84%.

More news about Broadwind.

3. Asure Software (ASUR) – -6.12%

Asure Software, Inc. offers cloud-based solutions for human capital management in the United States. The company helps small- and medium-sized companies to build human capital, keep compliant and invest in growth. Asure Payroll & Tax is a comprehensive cloud-based software solution that automates payroll regulations. This includes wages, bonuses, tips and overtime. Asure HR handles HR complexities such as employee self service that allows employees to view information, company documents, pay history and other company documents. Asure Time & Attendance provides ROI and cost savings. The company also offers HR services, which include an online compliance library as well as an on-demand phone number for any HR queries. Asure Software, Inc. is located in Austin, Texas.

NASDAQ ended the session with Asure Software dropping 6.12% to $5.37 on Tuesday while NASDAQ jumped 3.34% to $11,176.41.

Earnings Per Share

As for profitability, Asure Software has a trailing twelve months EPS of $0.09.

PE Ratio

Asure Software has a trailing twelve months price to earnings ratio of 59.67. Meaning,
the purchaser of the share is investing $59.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.25%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Asure Software’s EBITDA is 417.11.

Moving Average

Asure Software’s worth is below its 50-day moving average of $5.44 and way under its 200-day moving average of $6.22.

Volume

Today’s last reported volume for Asure Software is 50002 which is 19.03% below its average volume of 61760.

More news about Asure Software.

4. Accelerate Diagnostics (AXDX) – -5.92%

Accelerate Diagnostics, Inc., a company that specializes in in vitro diagnosis, offers solutions to diagnose serious infections across the United States, Europe, Middle East, and Asia. Accelerate Pheno, an in vitro diagnostic system that can identify and test for antibiotic susceptibility of pathogens with serious and health-related infections (gram-positive or gram-negative), is offered by the company. The company also offers the Accelerate PhenoTest test kit, which provides results on patients with suspected bacteremia and fungemia. These are life-threatening conditions that pose a high risk of death and morbidity. In December 2012, Accelerate Diagnostics, Inc. was established. The previous name of the company was Accelr8 Technology Corporation. Accelerate Diagnostics, Inc. is located in Tucson, Arizona.

NASDAQ ended the session with Accelerate Diagnostics falling 5.92% to $1.43 on Tuesday while NASDAQ jumped 3.34% to $11,176.41.

Earnings Per Share

As for profitability, Accelerate Diagnostics has a trailing twelve months EPS of $-1.056.

More news about Accelerate Diagnostics.

5. Ascent Solar Technologies (ASTI) – -5.49%

Ascent Solar Technologies, Inc. manufactures, sells, and designs photovoltaic (PV), integrated consumer electronics as well as portable power applications. It serves military and commercial customers. The company offers outdoor solar chargers including XD-12, XD-248, and XD-50 for individual soldiers and platoons power requirements; super-low-voltage thin-film CIGS solar blankets; as well as solar modules. It sells products via distributors and value-added resellers as well as e-commerce businesses. Ascent Solar Technologies, Inc., was founded in 2005. It is located in Thornton, Colorado.

NASDAQ ended the session with Ascent Solar Technologies sliding 5.49% to $4.30 on Tuesday while NASDAQ jumped 3.34% to $11,176.41.

Earnings Per Share

As for profitability, Ascent Solar Technologies has a trailing twelve months EPS of $-1.445.

Yearly Top and Bottom Value

Ascent Solar Technologies’s stock is valued at $4.30 at 17:34 EST, way below its 52-week high of $11.50 and above its 52-week low of $4.19.

More news about Ascent Solar Technologies.

6. Cara Therapeutics (CARA) – -5.13%

Cara Therapeutics, Inc. is a biopharmaceutical company in clinical stage. It specializes in developing and marketing chemical entities that target pain and pruritus. Company is currently developing products that target immune cells and the peripheral nervous system. KORSUVA, CR845/difelikefalin), is the company’s leading product candidate. It is currently in Phase III clinical trials for patients suffering from moderate-to-severe chronic renal disease-associated pruritus. The company is also developing Oral KORSUVA (CR845/difelikefalin), which has completed Phase II clinical trial for the treatment of pruritus in stage III-V CKD patients; in Phase II clinical trial for treating pruritus chronic liver disease; and in Phase II clinical trial for the treatment of pruritus associated with atopic dermatitis. It is also developing CR845/difelikefalin Injection. This has just completed the Phase II/III clinical trials for acute post-operative pain. Maruishi Pharmaceutical Co., Ltd has licensed the company to create, manufacture, commercialize and market drug products that contain CR845/difelikefalin to treat acute pain in Japan and uremic pruritus. Chong Kun Dang Pharmaceutical Corporation will develop, produce, and sell drug products that are CR845/difelikefalin-containing products in South Korea. Cara Therapeutics, Inc., was established in 2004. It is located in Stamford, Connecticut.

NASDAQ ended the session with Cara Therapeutics sliding 5.13% to $8.88 on Tuesday while NASDAQ jumped 3.34% to $11,176.41.

Earnings Per Share

As for profitability, Cara Therapeutics has a trailing twelve months EPS of $-1.8.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.53%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 1950% and positive 63.5% for the next.

Yearly Top and Bottom Value

Cara Therapeutics’s stock is valued at $8.88 at 17:34 EST, way below its 52-week high of $18.93 and way higher than its 52-week low of $7.40.

More news about Cara Therapeutics.

7. Catalyst Pharmaceuticals (CPRX) – -3.46%

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical firm at the commercial stage. It specializes in developing and marketing therapies for patients with neurological, debilitating, or chronic neuromuscular diseases. Firdapse is an amifampridine-phosphate tablet for patients suffering from lambert–eaton syndrome (LEMS). Ruzurgi can be used to treat LEMS children. Firdapse is also developed by the company to treat MuSK antibody positive myasthenia Gravis and spinal muscular atrophy Type 3. It can also be used to treat hereditary nervepathy with liability for pressure palsies. Endo Ventures Limited and BioMarin Pharmaceutical Inc. have license agreements. Endo Ventures Limited has a collaboration agreement for the commercialization and development of generic Sabril tablets. Catalyst Pharmaceutical Partners, Inc. was the company’s former name. It changed its name in May 2015 to Catalyst Pharmaceuticals, Inc. Catalyst Pharmaceuticals, Inc., was established in 2002. It is located in Coral Gables, Florida.

NASDAQ ended the session with Catalyst Pharmaceuticals falling 3.46% to $12.69 on Tuesday while NASDAQ jumped 3.34% to $11,176.41.

Earnings Per Share

As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.71.

PE Ratio

Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 17.87. Meaning,
the purchaser of the share is investing $17.87 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.59%.

More news about Catalyst Pharmaceuticals.

8. ProShares UltraShort Nasdaq Biotechnology (BIS) – -3.17%

NASDAQ ended the session with ProShares UltraShort Nasdaq Biotechnology falling 3.17% to $24.47 on Tuesday, following the last session’s downward trend. NASDAQ rose 3.34% to $11,176.41, following the last session’s upward trend on what was a very bullish trend trading session today.

Volume

Today’s last reported volume for ProShares UltraShort Nasdaq Biotechnology is 24247 which is 15.82% below its average volume of 28804.

More news about ProShares UltraShort Nasdaq Biotechnology.

9. bluebird bio (BLUE) – -3.16%

bluebird bio, Inc. is a biotechnology firm that develops, markets, and sells gene therapies to treat severe genetic disorders and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent AY-thalassemia; LentiGlobin for the treatment of sickle cell disease; and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. Idecabtagene Vicleucel, and bb21217 are the company’s oncology product candidates. These products can be used to treat multiple myeloma by using chimeric antigen receptor (CAR) T cell product candidates. There are license and collaboration agreements with Bristol-Myers Squibb, Regeneron Pharmaceuticals, Inc., Novartis Pharma AG, Orchard Therapeutics Limited, Medigene AG, Novo Nordisk A/S, Forty Seven, Inc., Gritstone oncology, Inc., Magenta Therapeutics, Inc., University of North Carolina, Fred Hutchinson Cancer Research Center, as well as Bristol-Myers Squibb. bluebird bio, Inc. is a member of a strategic alliance with National Resilience, Inc. for the development, delivery, and research in cell therapies. The original name of the company was Genetix Pharmaceuticals, Inc., but it was renamed bluebird bio, Inc. on September 10, 2010. bluebird bio, Inc. is headquartered at Cambridge, Massachusetts.

NASDAQ ended the session with bluebird bio falling 3.16% to $6.13 on Tuesday, following the last session’s downward trend. NASDAQ jumped 3.34% to $11,176.41, following the last session’s upward trend on what was a very bullish trend exchanging session today.

Earnings Per Share

As for profitability, bluebird bio has a trailing twelve months EPS of $-9.95.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.97%.

Moving Average

bluebird bio’s value is higher than its 50-day moving average of $5.90 and above its 200-day moving average of $5.67.

More news about bluebird bio.

10. BioLife Solutions (BLFS) – -2.55%

BioLife Solutions Inc. designs, produces, and sells bioproduction tools for gene and cell therapy industries in America, Canada, Europe and the Middle East. Products are used for basic and applied research as well as commercial production of biologic-based treatments. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It sells products both directly and through distributors. BioLife Solutions Inc. was established in 1987. It is located in Bothell Washington.

NASDAQ ended the session with BioLife Solutions dropping 2.55% to $22.17 on Tuesday, after three sequential sessions in a row of losses. NASDAQ jumped 3.34% to $11,176.41, following the last session’s upward trend on what was a very bullish trend exchanging session today.

Earnings Per Share

As for profitability, BioLife Solutions has a trailing twelve months EPS of $-0.04.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.95%.

More news about BioLife Solutions.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here